For Healthcare Professionals

The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies.


About the study

Safety and tolerability of monotherapy or combination in patients that have participated in a previous parent study to treat advanced malignancies.

Who can take part

You may be eligible to participate in the study if you meet the following criteria:


Inclusion Criteria:

  1. Currently enrolled and receiving treatment in an Incyte-sponsored clinical study (parent protocol) of pemigatinib as monotherapy or combination therapy.
  2. Currently benefiting from and tolerating treatment with pemigatinib, as determined by the investigator.
  3. Demonstrated compliance, as assessed by the investigator, with the parent protocol requirements.
  4. Willingness and ability to comply with scheduled visits, treatment plans, and any other study procedures.
  5. Currently have no evidence of progressive disease, as determined by the investigator, following treatment with pemigatinib as monotherapy or combination therapy.
  6. Willingness to avoid pregnancy or fathering children.


Exclusion Criteria:

  1. Able to access pemigatinib commercially or outside of a clinical trial.
  2. Permanently discontinued from the parent protocol for any reason.
  3. No longer meet the inclusion/exclusion criteria from the parent protocol if still receiving treatment.

  4. Women who are pregnant or breastfeeding or participants expecting to conceive or father children within the projected duration of the study.

pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply

Contact the study center to learn if this study is a good match for you.

Study’s details


Advanced Malignancies

Age (in years)

18 - 90


Phase 2

Participants needed


Est. Completion Date

Dec 29, 2023

Treatment type



Incyte Corporation identifier


Study number

INCB 54828-801

Understanding Clinical Trials

Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?


Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.